Innoviva is committed to building long-lasting value and improving patient care.
Business Model:
Revenue: $373.2M
Employees: 2-10
Address: 1350 Old Bayshore Hwy
City: Burlingame
State: CA
Zip: 94010
Country: US
Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.
Contact Phone:
+16502389600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/8/2004
Ticker Symbol:
INVA
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2023 | Armata Pharmaceuticals | Post-IPO Debt | 30M |
10/2021 | Armata Pharmaceuticals | Post-IPO Equity | 7M |
2/2022 | Armata Pharmaceuticals | Post-IPO Equity | 45M |
10/2022 | Gate Neurosciences | Venture Round | 25M |
9/2022 | Nanolive | Series C | 2.2M |
10/2020 | InCarda Therapeutics | Series C | 30M |
2/2022 | Armata Pharmaceuticals | Post-IPO Equity | 0 |
10/2021 | Armata Pharmaceuticals | Post-IPO Equity | 0 |
10/2020 | InCarda Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|